MARKER THERAPEUTICS, INC. Adjustments to Additional Paid in Capital, Warrant Issued
MARKER THERAPEUTICS, INC. (MRKR) reported Adjustments to Additional Paid in Capital, Warrant Issued of $728.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-12.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2020-03-12
- MARKER THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2018-12-31 was $0.00.
- MARKER THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2018-09-30 was $0.00.
- MARKER THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2018-06-30 was $0.00.
- MARKER THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2017-12-31 was $0.00.
- MARKER THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2019 was $728.00K.
- MARKER THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2018 was $0.00.
- MARKER THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- MARKER THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2016 was $5.07M, a 69.86% decline from fiscal 2015.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|
| 2019-12-31 | $728.00K 10-K · filed 2020-03-12 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $0.00 derived: sum of 3 quarters · filed 2019-11-12 | $0.00 10-K · filed 2019-03-15 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $0.00 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $0.00 10-Q · filed 2019-08-09 | $0.00 10-Q · filed 2019-08-09 | ||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $0.00 derived: sum of 2 quarters · filed 2019-03-15 | $0.00 10-K · filed 2019-03-15 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $0.00 10-Q · filed 2017-11-14 | ||
| 2017-06-30 | $0.00 10-Q · filed 2017-08-07 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-23 | $5.07M 10-K · filed 2018-03-23 | ||
| 2016-09-30 | $5.07M 10-Q · filed 2016-11-04 | |||
| 2015-12-31 | $16.84M 10-K · filed 2017-03-14 | |||
| 2015-06-30 | $2.50M 10-Q/A · filed 2016-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |